These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 11517161

  • 1. E2-induced degradation of uterine insulin receptor substrate-2: requirement for an IGF-I-stimulated, proteasome-dependent pathway.
    Richards RG, Klotz DM, Bush MR, Walmer DK, DiAugustine RP.
    Endocrinology; 2001 Sep; 142(9):3842-9. PubMed ID: 11517161
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.
    Richards RG, Walker MP, Sebastian J, DiAugustine RP.
    J Biol Chem; 1998 May 08; 273(19):11962-9. PubMed ID: 9565625
    [Abstract] [Full Text] [Related]

  • 3. Interdependence of epidermal growth factor and insulin-like growth factor-I expression in the mouse uterus.
    Hana V, Murphy LJ.
    Endocrinology; 1994 Jul 08; 135(1):107-12. PubMed ID: 8013342
    [Abstract] [Full Text] [Related]

  • 4. Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-1 receptor and insulin receptor substrate-1 in the uterus.
    Richards RG, DiAugustine RP, Petrusz P, Clark GC, Sebastian J.
    Proc Natl Acad Sci U S A; 1996 Oct 15; 93(21):12002-7. PubMed ID: 8876252
    [Abstract] [Full Text] [Related]

  • 5. Impaired estrogen action in the uterus of insulin-like growth factor binding protein-1 transgenic mice.
    Rajkumar K, Dheen T, Krsek M, Murphy LJ.
    Endocrinology; 1996 Apr 15; 137(4):1258-64. PubMed ID: 8625897
    [Abstract] [Full Text] [Related]

  • 6. Cellular localization and sex steroid regulation of insulin-like growth factor binding protein messenger ribonucleic acids in the primate myometrium.
    Adesanya OO, Zhou J, Bondy CA.
    J Clin Endocrinol Metab; 1996 Jul 15; 81(7):2495-501. PubMed ID: 8675566
    [Abstract] [Full Text] [Related]

  • 7. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.
    Haruta T, Uno T, Kawahara J, Takano A, Egawa K, Sharma PM, Olefsky JM, Kobayashi M.
    Mol Endocrinol; 2000 Jun 15; 14(6):783-94. PubMed ID: 10847581
    [Abstract] [Full Text] [Related]

  • 8. Combinatorial effects of the phytoestrogen genistein and of estradiol in uterus and liver of female Wistar rats.
    Diel P, Hertrampf T, Seibel J, Laudenbach-Leschowsky U, Kolba S, Vollmer G.
    J Steroid Biochem Mol Biol; 2006 Dec 15; 102(1-5):60-70. PubMed ID: 17049845
    [Abstract] [Full Text] [Related]

  • 9. Proteasomal degradation of IRS-2, but not IRS-1 by calcineurin inhibition: attenuation of insulin-like growth factor-I-induced GSK-3beta and ERK pathways in adrenal chromaffin cells.
    Satoh S, Yanagita T, Maruta T, Nemoto T, Yoshikawa N, Kobayashi H, Tono T, Wada A.
    Neuropharmacology; 2008 Jul 15; 55(1):71-9. PubMed ID: 18538359
    [Abstract] [Full Text] [Related]

  • 10. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
    Takano A, Usui I, Haruta T, Kawahara J, Uno T, Iwata M, Kobayashi M.
    Mol Cell Biol; 2001 Aug 15; 21(15):5050-62. PubMed ID: 11438661
    [Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells.
    Kim B, van Golen CM, Feldman EL.
    Endocrinology; 2005 Dec 15; 146(12):5350-7. PubMed ID: 16150916
    [Abstract] [Full Text] [Related]

  • 12. Differential regulation of heparin-binding epidermal growth factor-like growth factor in the adult ovariectomized mouse uterus by progesterone and estrogen.
    Wang XN, Das SK, Damm D, Klagsbrun M, Abraham JA, Dey SK.
    Endocrinology; 1994 Sep 15; 135(3):1264-71. PubMed ID: 8070372
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
    Chan TW, Pollak M, Huynh H.
    Clin Cancer Res; 2001 Aug 15; 7(8):2545-54. PubMed ID: 11489838
    [Abstract] [Full Text] [Related]

  • 14. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X, Lazard Z, Zhang P, Hopp TA, Lee AV.
    Oncogene; 2003 Oct 09; 22(44):6937-41. PubMed ID: 14534541
    [Abstract] [Full Text] [Related]

  • 15. Expression of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in the rat uterus during decidualization.
    Croze F, Kennedy TG, Schroedter IC, Friesen HG, Murphy LJ.
    Endocrinology; 1990 Oct 09; 127(4):1995-2000. PubMed ID: 1698151
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential expression of epidermal growth factor receptor (EGF-R) gene and regulation of EGF-R bioactivity by progesterone and estrogen in the adult mouse uterus.
    Das SK, Tsukamura H, Paria BC, Andrews GK, Dey SK.
    Endocrinology; 1994 Feb 09; 134(2):971-81. PubMed ID: 7507841
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
    Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D.
    Mol Endocrinol; 1999 May 09; 13(5):787-96. PubMed ID: 10319328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.